Suppliers / Aspiro Pharma

Aspiro Pharma

India Updated 9 July 2026

Aspiro Pharma is a finished-dose manufacturer based in India. It appears in 168 regulatory filings across 12 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), INVIMA (CO) and ARCSA (EC). Its GMP standing is certified by EAEU_EEC, ANVISA (Brazil) and NAFDAC (NG), among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 11 August 2023 as VAI. Customs aggregates show $52.5M of exports covering 816 molecules to 36 destinations in 2025.

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
168
filings across 12 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 11 August 2023 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
SIDDIPET, India Not on file
Siddipet, India 3014483338
Siddpet District Telengana, Nigeria Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
DIGEMAPS (DO) 99 None
INVIMA (CO) 20 None
ARCSA (EC) 13 None
MINSA (CR) 9 None
UZPHARM (UZ) 7 None
JFDA (JO) 6 None
EAEU_EEC None 2
ANVISA (Brazil) None 2
NAFDAC (NG) None 2
US FDA None 1
EMA None 1

Scale

Year Revenue Exports Destinations
2025 Not reported $52.5M 36
2024 Not reported $43.1M 34
2023 Not reported $17.7M 28
2022 Not reported $9.8M 26

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Aspiro Pharma

Does Aspiro Pharma hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Aspiro Pharma. It does have 168 filings with 12 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Aspiro Pharma FDA-registered?
One site operated by Aspiro Pharma carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Aspiro Pharma's last inspection go?
The most recent inspection on record closed on 11 August 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 1 inspection is on file.
Where does Aspiro Pharma manufacture?
3 registered sites are on record, in India and Nigeria (Siddipet, Siddipet and Siddpet District Telengana). Every site is listed on this page with the register it came from.
Which regulators recognise Aspiro Pharma's GMP?
Current GMP certificates are on record from EEC (Eurasian Economic Union), ANVISA (Brazil), NAFDAC (NG), US FDA and EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Aspiro Pharma comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 11 August 2023.

Comparable suppliers

Abbott Healthcare also in India Accent Pharmaceuticals Diagnostics also in India Accure Labs Pvt.Ltd also in India ACME Formulation also in India Acme Generics also in India

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts